Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PMCK BhdXKLS:0363 -2.38%21 Debt-to-EBITDA is 2.09 as of Apr. 2026, which is 232% above its 10-year median of 0.63. GuruFocus rates XKLS:0363 with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 478 Healthcare Providers & Services companies, PMCK Bhd ranks better than 57.11% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for PMCK Bhd's Debt-to-EBITDA or its related term are showing as below:
XKLS:0363'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.54 Med: 0.63 Max: 1.71
Current: 1.71
During the past 5 years, the highest Debt-to-EBITDA Ratio of PMCK Bhd was 1.71. The lowest was 0.54. And the median was 0.63.
XKLS:0363's Debt-to-EBITDA is ranked better than 57.11% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs XKLS:0363: 1.71
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PMCK Bhd Debt-to-EBITDA Related Terms
PMCK Bhd Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for PMCK Bhd's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0363 vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PMCK Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMCK Bhd Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PMCK Bhd's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PMCK Bhd's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Apr. 2026) EBITDA data.
PMCK Bhd (XKLS:0363) has a Debt-to-EBITDA of 2.09 as of Apr. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PMCK Bhd. This is 232% above median its historical median of 0.63. Over the past decade, PMCK Bhd's Debt-to-EBITDA has ranged from 0.54 to 1.71. According to the industry distribution chart, PMCK Bhd ranks #205 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 42.9%.
Is PMCK Bhd's Debt-to-EBITDA too high?
PMCK Bhd's current Debt-to-EBITDA of 2.09 is 232% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 1.71. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. PMCK Bhd's value of 2.09 is 4.3% below this industry median. Based on the distribution chart, PMCK Bhd ranks #205 out of 478 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PMCK Bhd has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PMCK Bhd's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PMCK Bhd ranks #205 out of 478 companies for Debt-to-EBITDA. This puts PMCK Bhd in the upper half of its industry. The industry median Debt-to-EBITDA is 2.19. PMCK Bhd's value of 2.09 is 4.3% below this benchmark. Historically, PMCK Bhd's own Debt-to-EBITDA has ranged from 0.54 to 1.71 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 2.19, PMCK Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMCK Bhd's current Debt-to-EBITDA of 2.09 is 4.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PMCK Bhd. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMCK Bhd's current Debt-to-EBITDA is 2.09, which is 232% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMCK Bhd stock overvalued right now?
PMCK Bhd (XKLS:0363) has a current Debt-to-EBITDA of 2.09. The current Debt-to-EBITDA is 2.09, which is 232% above median its 10-year median of 0.63 and 4.3% below the Healthcare Providers & Services industry median of 2.19. PMCK Bhd's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PMCK Bhd (XKLS:0363), the current Debt-to-EBITDA is 2.09 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMCK Bhd is a healthcare service provider in Malaysia operating through its Putra Medical Centre. The company focuses on specialist consultant services across various medical fields such as anaesthesiology, cardiology, dermatology, emergency medicine, internal medicine, ophthalmology, orthopaedics, paediatrics, radiology, and surgery among others. Also, it provides healthcare support services including facility management, ward services, clinical support, medication sales, and nursing care, as well as general dental, polyclinic, and medical laboratory services. PMCK generates revenue majorly from these healthcare services and has a broad panel coverage with multiple insurance companies and government agencies facilitating patient access.
21GF Score
Get the complete analysis for XKLS:0363
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0363 has been successfully added to your 
